Anika Therapeutics, Inc.
Cash Flow Statement
| Line Item | FY2009 |
|---|---|
| Operating Activities | |
| Net Income | $3.7M |
| Depreciation & Amortization | $1.3M |
| Depreciation | — |
| Amortization | — |
| Stock-Based Compensation | $958.0K |
| Net Cash from Operating Activities | $3.1M |
| Investing Activities | |
| Capital Expenditures | $4.0M |
| Business Acquisitions | $16.3M |
| Net Cash from Investing Activities | $-20.2M |
| Financing Activities | |
| Dividends Paid | — |
| Stock Repurchases | — |
| Net Cash from Financing Activities | $-1.6M |
| Net Change in Cash | $-18.8M |
| Free Cash Flow | $-867.5K |